|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Acacia Research Corp., of Newport Beach, Calif., said a wholly owned subsidiary in its Acacia Technologies group acquired rights to patents relating to purifying nucleic acids. Those patents generally relate to methods and equipment used to purify plasmid DNA products, and may be used in production of nucleic acids for DNA vaccines and gene therapies. Neither the terms nor the licensor was disclosed.
o Amarin Corp. plc, of London, said it received a Nasdaq deficiency letter indicating it was not in compliance with the minimum bid price requirement for continued listing. Amarin will be provided with 180 calendar days, until Dec. 3, to regain compliance, which ...